EXPERIMENTAL BRAIN RESEARCH is a renowned journal published by SPRINGER, dedicated to advancing understanding in the field of neuroscience. With a history dating back to 1966, this journal offers valuable insights into the mechanisms of brain function and neurological disorders, making it a vital resource for researchers, professionals, and students alike. While it currently holds a Q3 classification in the field of Neuroscience (miscellaneous) and ranks #73 out of 113 in Scopus's General Neuroscience category, it continually contributes to fostering innovative research and collaborative dialogue. The journal is not open access, ensuring that although content is subscription-based, it maintains a high standard of peer review and scholarly rigor. By covering a breadth of topics relevant to both experimental and theoretical aspects of brain research, EXPERIMENTAL BRAIN RESEARCH serves as an essential platform for disseminating cutting-edge discoveries and theories in the dynamic realm of neuroscience.

The International Archives of Otorhinolaryngology is a leading peer-reviewed journal dedicated to the field of otorhinolaryngology, published by GEORG THIEME VERLAG KG. With an E-ISSN of 1809-4864, this Open Access journal has been committed to disseminating high-quality research since its inception in 2012, enabling researchers and practitioners worldwide to access the latest advancements and insights without barriers. Recognized in 2023 as a Q2 journal in the Otorhinolaryngology category, it ranks 57th out of 123 in Scopus, placing it in the 54th percentile, indicating its influence and relevance in the field. Covering a wide array of topics from clinical practices to innovative research, the journal serves as an essential resource for professionals, researchers, and students aiming to enhance their understanding and practice within this specialty. Its diverse content and dedication to promoting scientific inquiry make the International Archives of Otorhinolaryngology a cornerstone in the advancement of knowledge in ear, nose, and throat medicine.

DYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.

Neuron is a premier journal in the field of neuroscience, published by CELL PRESS in the United States. Since its inception in 1988, this esteemed publication has been at the forefront of neuroscientific research and continues to shape our understanding of the brain and nervous system. With an impressive 2023 Scopus rank of #5 out of 113 in General Neuroscience and a notable Q1 quartile classification, Neuron is recognized for its high-quality, impactful contributions to both established and emerging areas of neuroscience. The journal does not operate under an open access model, yet it offers unparalleled insights and rigorous peer-reviewed research that are essential for researchers, professionals, and students alike. By publishing cutting-edge findings and fostering critical discussions, Neuron plays a vital role in advancing our collective knowledge in this constantly evolving field, making it an indispensable resource for anyone aiming to stay ahead in neuroscience research.

Auditory and Vestibular Research is an esteemed open-access journal published by Tehran University of Medical Sciences, dedicated to advancing the field of otorhinolaryngology and speech and hearing sciences. Established to foster scholarly communication, this journal has gained traction since its inception and has been openly accessible since 2015, encouraging a wider dissemination of research findings. With an E-ISSN of 2423-480X, it features a diverse range of studies and reviews that reflect the latest advancements and methodologies in auditory and vestibular functioning. As of 2023, the journal is ranked Q3 in both Otorhinolaryngology and Speech and Hearing categories, indicating a growing significance within the academic landscape, especially among researchers and healthcare professionals focusing on auditory health. By publishing quality research and facilitating dialogue within the community, Auditory and Vestibular Research plays a crucial role in informing practice and enhancing knowledge in these vital areas of medicine.

Multiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.

Welcome to the American Journal of Audiology, a leading publication in the field of audiology and speech-language pathology, published by the American Speech-Language-Hearing Association. With an ISSN of 1059-0889 and E-ISSN of 1558-9137, this journal provides a vital platform for researchers and practitioners to share innovative studies, clinical practices, and evidence-based findings spanning over two decades, from 1996 to 2024. As a recognized authority in its category, the journal holds a Q2 rank in Speech and Hearing as per the 2023 category quartiles, and ranks #25 out of 66 in Scopus for Health Professions, landing it in the 62nd percentile for this field. Although not open access, the journal remains dedicated to advancing the science of audiology, aiming to enhance the professional community's knowledge and contribute to improved patient care. Addressed from 2200 Research Blvd, #271, Rockville, MD 20850-3289, the American Journal of Audiology is essential for those looking to stay at the forefront of research and trends in audiology.

EAR AND HEARING, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal dedicated to advancing the fields of Otorhinolaryngology and Speech and Hearing. With an ISSN of 0196-0202 and an E-ISSN of 1538-4667, this prestigious journal has established itself as a leading resource for researchers and clinicians alike since its inception in 1980. As of 2023, it proudly occupies Q1 quartile positions in both Otorhinolaryngology and Speech and Hearing, reflecting its influence and impact in the scientific community, further underscored by its exceptional Scopus rankings—#1 in Speech and Hearing and #9 in Otorhinolaryngology. Although it does not offer Open Access options, EAR AND HEARING remains an invaluable repository of cutting-edge research, reviews, and clinical insights that aim to enhance understanding and treatment of auditory and vestibular disorders. Its relevance is amplified by a comprehensive scope that encompasses innovative clinical practices and fundamental research, making it an essential read for researchers, professionals, and students dedicated to improving auditory health.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.